Amsacrine-induced mutations in AS52 cells

Environmental and Molecular Mutagenesis

Volumn 32, Issue 1, 1998, Pages 47-55

  Ferguson, Lynnette R ^a   Turner, Pamela M ^a   Hart, Daniel W ^b   Tindall, Kenneth R ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Amsacrine; AS52 cells; Mutation spectrum; Recombination; Topoisomerase II inhibition

Indexed keywords

AMSACRINE; TIOGUANINE;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; DNA SEQUENCE; GENE DELETION; GENE REARRANGEMENT; MUTAGENICITY; MUTANT; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

AMSACRINE; ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; CELL LINE; CHO CELLS; CRICETINAE; MUTAGENS; MUTATION; POLYMERASE CHAIN REACTION; THIOGUANINE;

ANIMALIA; BACTERIA (MICROORGANISMS); CRICETINAE; CRICETULUS GRISEUS;

EID: 0031879370     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1998)32:1<47::AID-EM6>3.0.CO;2-8     Document Type: Article

References (35)

1. Amundson SA, Liber HL (1991): A comparison of induced mutation at homologous alleles of the tk locus in human cells. Mutat Res 247:19-27.
2. An J, Hsie AW (1993): Polymerase chain reaction-based deletion screening of bleomycin induced 6-thioguanine resistant mutants in Chinese hamster ovary cells: The effects of an inhibitor and a mimic of Superoxide dismutase. Mutat Res 289:215-222.
3. Backer LC, Allen JW, Harrington-Brock K, Campbell JA, DeMarini DM, Doerr CL, Howard DR, Kligerman AD, Moore MM (1990): Genotoxicity of inhibitors of DNA topoisomerase I (camptothecin) and II (m-AMSA) in vivo and in vitro. Mutagenesis 5:541-547.
4. Bae YS, Chiba M, Ohira M, Ikeda H (1991): A shuttle vector for analysis of illegitimate recombination in mammalian cells: Effects of DNA topoisomerase inhibitors on deletion frequency. Gene 101:285-289.
5. Berger NA, Chetterjee S, Sehmotzer JA, Helms SR (1991): Etoposide-(VP-16-213)-induced gene alterations - Potential contribution to cell death. Proc Natl Acad Sci USA 88:8740-8743.
6. Chiewchanwit T, Ma H, El Zein R, Hallberg L, Au WW (1995): Induction of deletion mutations by methoxyacetaldehyde in Chinese hamster ovary (CHO)-AS52 cells. Mutat Res 335:121-128.
7. +/- mouse lymphoma cells. Mutagenesis 5:191-197.
8. Crossen P (1978): The effect of acridine compounds on sister chromatid formation in cultured human lymphocytes. Mutat Res 68:295-299.
9. Deaven LL, Oka MS, Tobey RA (1978): Cell-cycle-specific chromosome damage following treatment of cultured CHO cells with 4″-[9-acridinyl)-amino]methanesulphon-m-anisidide-HCI (m-AMSA chloride) J Natl Cancer Inst 60:1155-1159.
10. de la Inglesia FA, Fitzgerald JE, McGuire EJ, Kim S-N, Heiflitz CL, Stoner GD (1984): Bacterial and mammalian mutagenesis, sister chromatid exchange and mouse lung adenoma bioassay with the antineoplastic acridine derivative, J Toxicol Environ Health 14:667-681.
11. DeMarini DM, Doerr CL, Meyer MK, Brock KH, Hozier J, Moore MM (1987): Mutagenicity of m-AMSA and o-AMSA in mammalian cells due to clastogenic mechanism: Possible role of topoisomerase. Mutagenesis 2:349-355.
12. DeMarini DM, Brockman HE, de Serres FJ, Evans HH, Stankowski LF Jr, Hsie AW (1989): Specific-locus mutations induced in eukaryotes (especially mammalian cells) by radiation and chemicals: A perspective. Mutat Res 220:11-29.
13. Dillehay LE, Jacobson-Kram D, Williams JR (1989): DNA topoisomerases and models of sister chromatid exchange. Mutat Res 215:15-23.
14. Ferguson LR, Baguley BC (1984): Relationship between the induction of chromosome damage and cytotoxicity for amsacrine and congeners. Cancer Treat Rep 68:625-630.
15. Ferguson LR, Baguley BC (1994): Topoisomerase II enzymes and mutagenicity. Environ Mol Mutagen 24:245-261.
16. Ferguson LR, Denny WA (1979): Potential antitumour agents. 30. Mutagenic activity of some 9-anilinoacridines. Relationship between structure, mutagenic potential and antitumour activity. J Med Chem 22:251-255.
17. Fuscoe JC, Zimmerman LJ, Fekete A, Setzer RW, Rossiter BJ (1992a): Analysis of X-ray-induced Hprt mutations in CHO cells: Insertion and deletions. Mutat Res 269:171-183.
18. Fuscoe JC, Zimmerman LJ, Harrington-Brock K, Moore MM (1992b): Large deletions are tolerated at the hprt locus of in vivo derived human T-lymphocytes. Mutat Res 283:255-262.
19. Hun YH, Austin MJF, Povirk LF (1993): Small deletion and insertion mutations induced by the topoisomerase-II inhibitor teniposide in CHO cells and comparison with sites of drug-stimulated DNA cleavage in vitro. J Mol Biol 229:52-66.
20. Hart DW, Tindall KR (1996): Molecular characterisation of the gpt genomic site in AS52 cells. Environ Mol Mutagen 27(Suppl 27):28.
21. Liber HL, Yandell DW, Little JB (1989): A comparison of mutation at the tk and HPRT loci in human lymphoblastoid cells; quantitative differences are due to an additional class of mutations at the autosomal tk locus. Mutat Res 216:9-17.
22. Lippert MJ, Nicklas JA, Hunter TC, Albertini RJ (1995): Pulsed field analysis of HPRT T-cell large deletions: Telomeric region breakpoint spectrum. Mutat Res 326:51-64.
23. Morris T, Thacker J (1993): Formation of large deletions by illegitimate recombination in the HPRT gene of primary human fibroblasts. Proc Natl Acad Sci USA 90:1392-1396.
24. Mueller L, Kasper P, Madle H, Kaufmann G (1997): On the ability of the XPRT assay with AS52 cells to pick up clastogens and aneuploidy inducers. Environ Mol Mutagen 29(Suppl 28):37.
25. Osheroff N, Corbett AH, Elsea SH, Westergaard M (1994): Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classes. Cancer Chemother Pharmacol 34:S19-S25.
26. Richardson KK, Fostel J, Skopek TR (1983): Nucleotide sequence of the xanthine guanine phosporibosyl transferase gene of E. coli. Nucleic Acids Res 11:8809-8816.
27. Sambrook J, Fritsch EF, Maniatis T (1989): "Molecular Cloning, A Laboratory Manual. 2nd Ed." Cold Spring Harbor, NY: Cold Spring Harbor Press.
28. Shibuya ML, Ueno AM, Vannais DB, Craven PA, Waldron CA (1994): Megabase pair deletions in mutant mammalian cells following exposure to amsacrine, an inhibitor of DNA topoisomerase II. Cancer Res 54:1092-1097.
29. Stankowski LF, Tindall KR (1987): Characterization of the AS52 cell line for use in mammalian cell mutagenesis studies. In Moore MM, DeMarini DM, de Serres FJ, Tindall KR (eds): "Banbury Report 28: Mammalian Cell Mutagenesis." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, pp 71-79.
30. Stankowski LF, Tindall KR, Hsie AW (1986): Quantitative and molecular analysis of ethyl methane sulfonate- and ICR-191-induced mutation in AS52 cells. Mutat Res 160:133-147.
31. Tindall KR, Stankowski LF (1987): Deletion mutations are associated with the differential-induced mutant frequency response of the AS52 and CHO-k1-BH4 cells. In Moore MM, DeMarini DM, de Serres FJ, Tindall KR(eds): "Banbury Report 28: Mammalian Cell Mutagenesis." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, pp 283-292.
32. Tindall KR, Stankowski LF (1989): Molecular analysis of spontaneous mutants at the gpt locus in Chinese hamster ovary (AS52) cells. Mutat Res 220:241-253.
33. Tindall KR, Stankowski LF, Machanoff R, Hsie AW (1984): Detection of deletion mutations in pSV2 gpt-transformed cells. Mol Cell Biol 4:1411-1415.
34. Tindall KR, Stankowski LF, Machanoff R, Hsie AW (1986): Analyses of mutation in pSV2gpt-transformed CHO cells. Mutat Res 160:121-131.
35. Wilson WR, Harris NM, Ferguson LR (1984): Comparison of the mutagenic and clastogenic activity of amsacrine and other DNA-intercalating drugs in cultured V79 Chinese hamster cells. Cancer Res 44:4420-4431.